Search - tctmd.com

Displaying 661 - 680 of 722

Sort: Relevancy | Date

Presentation TCT 2012

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Presenter: Michael Bohm

October 24, 2012

Presentation TCT 2012

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Extravascular Renal Denervation (Ablative Solutions)

Presenter: Tim Fischell

October 24, 2012

Presentation TCT 2012

Catheter-Based Technology Alternatives for Renal Denervation

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Beyond Renal Denervation

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Presenter: Christian Ukena

October 23, 2012

Presentation TCT 2012

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Presenter: Felix Mahfoud

October 23, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

Presentation TCT 2012

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

Presenter: Meital Mazor

October 23, 2012

Presentation TCT 2012

Hypertension: Renal Denervation

Presenter: Deepak Bhatt

October 23, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

News Industry News

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

October 22, 2012

Presentation TCT 2012

Renal Sympathetic Denervation for HTN

Presenter: Lynne Hinterbuchner

October 22, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

October 03, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

Presentation VEINS 2012

Renal Denervation: A Percutaneous Therapy for HTN

Presenter: Nilesh J. Goswami

September 15, 2012

Advertisement

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Extravascular Renal Denervation (Ablative Solutions)

Catheter-Based Technology Alternatives for Renal Denervation

Beyond Renal Denervation

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

Hypertension: Renal Denervation

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

Renal Sympathetic Denervation for HTN

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Renal Denervation: A Percutaneous Therapy for HTN

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content